Marshall Wace, LLP Harvard Bioscience Inc Transaction History

Marshall Wace, LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$4.19 - $6.16 $228,962 - $336,613	54,645 New	54,645 $300,000
Q3 2022 Nov 14, 2022	BUY	$2.33 - $3.92 $54,890 - $92,347	23,558 Added 44.15%	76,923 $196,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.42 $78,998 - $154,625	24,085 Added 82.26%	53,365 $192,000
Q2 2021 Aug 13, 2021	BUY	$5.44 - $8.4 $14,557 - $22,478	2,676 Added 10.06%	29,280 $244,000
Q1 2021 May 17, 2021	BUY	$3.91 - $6.99 $104,021 - $185,961	26,604 New	26,604 $145,000
Q1 2020 May 15, 2020	SELL	$1.42 - $3.29 $201,835 - $467,634	-142,138 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$2.45 - $3.25 $449,109 - $595,757	-183,310 Reduced 56.33%	142,138 $434,000
Q3 2019 Nov 14, 2019	SELL	$1.59 - $3.47 $138,966 - $303,278	-87,400 Reduced 21.17%	325,448 $1 Million
Q2 2019 Aug 14, 2019	BUY	$1.93 - $4.59 $629,768 - $1.5 Million	326,305 Added 377.04%	412,848 $826,000
Q1 2019 May 14, 2019	BUY	$2.77 - $4.38 $205,226 - $324,509	74,089 Added 594.9%	86,543 $373,000
Q4 2018 Feb 14, 2019	SELL	$3.03 - $5.0 $33,469 - $55,230	-11,046 Reduced 47.0%	12,454 $40,000
Q3 2018 Nov 14, 2018	BUY	$5.0 - $6.65 $117,500 - $156,275	23,500 New	23,500 $123,000

31.5M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.